SUMMARY To establish the prevalence of syphilis in pregnant women in Mozambique and evaluate present diagnostic methods, 1468 pregnant women in eight of the country's 10 provinces were examined using the Venereal Disease Research Laboratory (VDRL) test. Positive serum samples were also analysed using the Treponema pallidum haemagglutination (TPHA) assay and one group was also analysed using the fluorescent treponemal antibody absorbed (FTA-ABS) test.
Introduction
Active syphilis in a pregnant woman may cause spontaneous abortion, stillbirth, or congenital syphilis. When the neonate is affected, clinical symptoms may be manifest at birth or develop during the years of childhood. Serological tests for syphilis are therefore often routinely performed early in pregnancy.
The importance of pregnancy screening for syphilis in a country with limited health care resources must, however, be weighed against other needs. The prevalence of syphilis in pregnant women, laboratory capacity, and the possibility of treating infected women adequately must be considered from a cost benefit point of view when deciding whether or not to include routine serological screening for syphilis in a national maternal health care programme.
Syphilis is considerably more common in Africa than in Europe or in the United States of America. [1] [2] [3] In Zambia, for example, 6 5% of newborn children in Lusaka had serological signs of syphilis,4 and syphilis was a common diagnosis among children in hospital, which resulted in high mortality. 5 6 In Swaziland the estimated yearly incidence of syphilis among adults was as high as 1-4% . 7 In Mozambique no nationwide study of the prevalence of syphilis in pregnancy has as yet been performed. The purpose of the study published here was to estimate the prevalence of syphilis during pregnancy in Mozambique and to evaluate present diagnostic methods.
Patients and methods

PATIENTS
We studied two groups of pregnant women.
Group 1 consisted of 755 pregnant women examined during a nationwide study of maternal morbidity in 1982-3.8 The study was carried out in six of the country's 10 provinces, at sites underlined in the figure. About two thirds of these women lived in rural areas. At five of the six sites all the pregnant women in a defined area (village or part of town) were mobilised to participate, and the influence of local leaders and health workers was used to achieve maximum coverage. At the sixth site, Mbemba, the community approach was impossible for a number of practical reasons, so the study was performed in an antenatal care unit.
In Reagents from the Cellognost syphilis kit (Hoechst) were used.
The fluorescent treponemal antibody absorbed (FTA-ABS) test was performed in Stockholm on all VDRL positive serum samples from group 1. In group 1, 601 serum samples were also examined at the district or provincial hospital closest to the site where each woman was seen. The VDRL test was performed on these serum samples according to local routine. In cases where this result did not correspond with that obtained in Maputo, the test was repeated at the National Bacteriological Laboratory, Stockholm, Sweden. Table I shows the prevalence of VDRL seroreactivity in the women studied at each site as well as the degree of confirmation by treponema specific tests.
Results
A positive VDRL test reaction was found in 4 5% to 14 6% of the women examined, and 1 6% to 9-8% showed evidence of treponomal infection as confirmed by the specific tests, TPHA or FTA-ABS, or both. In the whole study population, 93 of the 121 reactors to the VDRL test were shown to have treponemal infection, giving a predictive value of a positive VDRL test reaction of 77%.
All VDRL positive serum samples from patients in group 1 underwent not only TPHA but also FTA-ABS analysis, and all but one of the 36 TPHA positive serum samples were also FTA-ABS positive. Of the 46 serum samples analysed in Maputo and in Stockholm, 44 In neighbouring countries the prevalence of syphilis has been studied in health institutions but not at community level as in our study (group 1). Thus 15 8% of parturients at the university hospital and 12-5% of antenatal care attenders in Lusaka, Zambia were reported to be seroreactive for syphilis,' 25 and 10-14% of antenatal and family planning care attenders in Swaziland were RPR positive.7 '3 Syphilis is evidently highly prevalent in the region.
The incidence of congenital syphilis in liveborn infants or of spontaneous abortion due to syphilis in Mozambique is not known. A parallel study of stillbirths in the capital city of Maputo indicated, however, that 13 out of 153 (8 5%) consecutive stillbirths were caused by syphilis (Axemo et al, unpublished observation). Congenital syphilis in liveborn infants has been studied in Lusaka, where 30 (6 4%) of 469 consecutive neonates were seropositive for syphilis, and four (0' 9%) of them developed signs of congenital syphilis.4 In a study in Addis Ababa 21* 3% of the babies of VDRL positive mothers developed congenital syphilis. '4 The perinatal complication rate is evidently high in regions where syphilis in pregnancy is common.
Measures to reduce the incidence of syphilis and its complications during pregnancy and among neonates J Liljestrand, S Bergstom, F Nieuwenhuis, and Bengt Hederstedt should be given high priority in perinatal care. As migrant labour, rapid urbanisation, war, and poverty are highly conducive to the spread of the disease, a community based approach with continuous adequate screening and treatment would be indispensable.
We conclude that syphilis during pregnancy is relatively common in Mozambique and that laboratory techniques should be improved at a local level. A positive VDRL test, when well performed, has a predictive value for syphilis of 77%.
